Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "RPA"

90 News Found

Research uncovers challenges for people with vascular disease
News | November 16, 2021

Research uncovers challenges for people with vascular disease

Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis


Indian Pharma Market witnesses rise in volumes and prices in September.
News | October 28, 2021

Indian Pharma Market witnesses rise in volumes and prices in September.

Acute therapies continue to report strong growth compared to chronic ones.


Biological E to receive US $ 50 million to boost Covid-19 vaccine capacity
Biotech | October 26, 2021

Biological E to receive US $ 50 million to boost Covid-19 vaccine capacity

Support from DFC will help produce one billion vaccine doses by the end of 2022


Jubliant FoodWorks leads Rs 11 crore funding in Wellversed
Startup | September 30, 2021

Jubliant FoodWorks leads Rs 11 crore funding in Wellversed

The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent


Morpen Labs carves out diagnostics business to unlock value
Diagnostic Center | September 29, 2021

Morpen Labs carves out diagnostics business to unlock value

The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India


Union Minister Jitendra Singh launch free telemedicine facility
Public Health | September 18, 2021

Union Minister Jitendra Singh launch free telemedicine facility

Telemedicine services like SAATH and E-Sanjeevani add a meta-layer to the primary health sector, thus helping upgrade the entire health care system of India


Max Ventilator forms partnership with US-based Amptron Medical
Drug Approval | September 07, 2021

Max Ventilator forms partnership with US-based Amptron Medical

Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.


Indian Railways to deploy HMIS across its network
Digitisation | September 04, 2021

Indian Railways to deploy HMIS across its network

Implementation of the system to provide faster, seamless and hassle-free healthcare solutions


Lasa Super Generics open for business
News | August 24, 2021

Lasa Super Generics open for business

Floods had forced the plans in Mahad to shut down


Abbott's Freestyle Libre 2 Ios App Cleared In U.S
Drug Approval | August 03, 2021

Abbott's Freestyle Libre 2 Ios App Cleared In U.S

FreeStyle Libre 2 iOS app is the only sensor-based glucose monitoring app that allows users to check their glucose with a compatible iPhone every minute with optional real-time glucose alarms